|Targets||Sphingosine 1 Phosphate Receptor|
|Description||CYM 50260 has been found to be a S1P4 agonist.|
|Purity||≥98% by HPLC|
|Synonyms||CYM-50260; CYM 50260; CYM50260. 2-Chloro-3-[2-(2,4-dichlorophenoxy)ethoxy]-6-(fluoromethyl)pyridine|
CYM 50308 has been found to be an effective and selective S1P4 agonist.
JTE 013 has been found to be an antagonist of Sphingosine-1-Phosphate Receptor-2 (S1P2R).
CYM 50260 has been found to be a S1P4 agonist.
The hydrochloride salt form of CYM 50358, which has been found to be an effective S1P4 antagonist.
The hydrochloride salt form of PF-543, a novel SphK1 inhibitor that could exhibit activity in induceing necrosis in human colorectal cancer cells in biological ...
This active moleclar is a Sphingosine 1 Phosphate Receptor antagonists for treatment of multiple sclerosis (MS) and other autoimmune diseases originated by Aren...
This active molecular is a S1P1/S1P5 agonist with limited activity at S1P3. AMG 369 has no activity at S1P2 and S1P4. AMG-369 is shown to reduce blood lymphocyt...
Ozanimod, also known as RPC1063, is a selective oral S1P Receptor 1 modulator.